MENU
BTAI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioXcel Therapeutics (BTAI) Earnings Date & Reports
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BTAI is expected to report earnings to fall 21.76% to -42 cents per share on August 11
Q2'26
Est.
$-0.42
Q1'26
Beat
by $2.49
Q4'25
Missed
by $0.49
Q3'25
Missed
by $2.09
Q2'25
Missed
by $2.32
The last earnings report on May 15 showed earnings per share of -54 cents, beating the estimate of -302 cents. With 439.37K shares outstanding, the current market capitalization sits at 37.05M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry PharmaceuticalsGeneric
Profile
Details
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
29
Web
https://www.bioxceltherapeutics.com